Endava is trading at $1.79, down 10.47%, as uncertainty around the accounting investigation continues to pressure shares.
- The independent investigation follows auditor concerns about the accounting treatment of certain customer and supplier agreements.
- Mark Thurston was placed on administrative leave in the September 21, 2026 announcement, and Conor McShane was appointed interim CFO. The decline extends Endavaβs September 23, 2026 close of $2.00.